Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIK1 | P39086 | 2/20 | 0.35 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | CPA1 | P15085 | 1/20 | 0.34 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL20474539 | 0.87 | GRIK1 (0.41) | GRIK1GRIK2CYP2C19CPA1ABCC4 | |
| SCHEMBL10941877 | 0.84 | GRIK1 (0.31) | GRIK1GRIK2 | |
| SCHEMBL29497160 | 0.78 | GRIK1 (0.45) | GRIK1GRIK2CYP2C19CPA1ABCC4 | |
| SCHEMBL31636 | 0.77 | GRIK1 (0.48) | GRIK1GRIK2CYP2C19CPA1ABCC4 | |
| Ammonia Solution, Strong SCHEMBL6396419 | 0.74 | GRIK1 (0.46) | GRIK1GRIK2CYP2C19CPA1ABCC4 | |
| SCHEMBL31299617 | 0.74 | GRIK1 (0.46) | GRIK1GRIK2CYP2C19CPA1ABCC4 | |
| Lithium SCHEMBL31299623 | 0.74 | GRIK1 (0.46) | GRIK1GRIK2CYP2C19CPA1ABCC4 | |
| Potassium SCHEMBL31299609 | 0.74 | GRIK1 (0.46) | GRIK1GRIK2CYP2C19CPA1ABCC4 | |
| SCHEMBL9622027 | 0.74 | — | — | |
| SCHEMBL2704693 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 207 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118255545-B | High-hardness silicon-free artificial stone plate and preparation method thereof | 东莞市欧亚轩装饰建材有限公司 | 2024-09-17 | — | — | CN | claimed |
| CN-118255545-A | High-hardness silicon-free artificial stone plate and preparation method thereof | 东莞市欧亚轩装饰建材有限公司 | 2024-06-28 | — | — | CN | claimed |
| CN-116836366-B | Super soft sponge | 东莞市腾崴塑胶制品有限公司 | 2024-01-30 | — | — | CN | claimed |
| CN-116836366-A | Super soft sponge | 东莞市腾崴塑胶制品有限公司 | 2023-10-03 | — | — | CN | claimed |
| EP-0018139-B1 | PYRIDO (2,3-D) PYRIMIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESSES FOR PREPARING THE PYRIDO (2,3-D) PYRIMIDINE DERIVATIVES | AMERICAN HOME PRODUCTS CORPORATION (US) | 1983-05-04 | — | — | EP | claimed |
| EP-0018139-A2 | Pyrido (2,3-d) pyrimidine derivatives, pharmaceutical compositions containing them and processes for preparing the pyrido (2,3-d) pyrimidine derivatives | AMERICAN HOME PRODUCTS CORPORATION (US) | 1980-10-29 | — | — | EP | claimed |
| EP-0010426-A1 | Pharmaceutical composition containing 3,4-dihydro-3-oxo-2-quinoxalines, novel such quinoxalines and processes for the production thereof | ELI LILLY AND COMPANY (US) | 1980-04-30 | — | — | EP | claimed |
| US-12616773-B2 | Bioadhesive compositions and methods of making the same | THE PENN STATE RESEARCH FOUNDATION (US) | 2026-05-05 | — | — | US | disclosed |
| WO-2025081182-A1 | CITRATE-BASED OCULAR IMPLANTS AND POLYMERS | THE PENN STATE RESEARCH FOUNDATION (US) | 2025-04-17 | — | — | WO | disclosed |
| US-20240409684-A1 | Ion-Crosslinked Polymeric or Oligomeric Compositions | THE PENN STATE RESEARCH FOUNDATION | 2024-12-12 | — | — | US | disclosed |
| CN-118255545-B | High-hardness silicon-free artificial stone plate and preparation method thereof | 东莞市欧亚轩装饰建材有限公司 | 2024-09-17 | — | — | CN | disclosed |
| EP-4001342-B1 | BIOELASTOMERS AND APPLICATIONS THEREOF | PENN STATE RES FOUND (US) | 2024-08-21 | — | — | EP | disclosed |
| CN-118255545-A | High-hardness silicon-free artificial stone plate and preparation method thereof | 东莞市欧亚轩装饰建材有限公司 | 2024-06-28 | — | — | CN | disclosed |
| US-4350817-A | 4-Cl, Br or I-3-Carboxy or cyano-1,2-dihydro-2-oxo-1,8-naphthyridine derivatives | AMERICAN HOME PRODUCTS CORPORATION (US) | 1982-09-21 | — | — | US | disclosed |
| US-4347362-A | HYPOTENSIVE | AMERICAN HOME PRODUCTS CORPORATION (US) | 1982-08-31 | — | — | US | disclosed |
| US-4324893-A | 4-Amino-3-carboxy or cyano-1,2-dihydro-2-oxo-1,8-naphthyridine derivatives | AMERICAN HOME PRODUCTS CORPORATION (US) | 1982-04-13 | — | — | US | disclosed |
| EP-0018735-A1 | 1,8-Naphthyridine derivatives, their preparation, pharmaceutical compositions containing them | AMERICAN HOME PRODUCTS CORPORATION (US) | 1980-11-12 | — | — | EP | disclosed |
| WO-1980002287-A1 | 1,8-NAPHTHYRIDINE DERIVATIVES | AMERICAN HOME PROD (US) | 1980-10-30 | — | — | WO | disclosed |
| EP-0010426-A1 | Pharmaceutical composition containing 3,4-dihydro-3-oxo-2-quinoxalines, novel such quinoxalines and processes for the production thereof | ELI LILLY AND COMPANY (US) | 1980-04-30 | — | — | EP | disclosed |
| EP-0010426-A1 | Pharmaceutical composition containing 3,4-dihydro-3-oxo-2-quinoxalines, novel such quinoxalines and processes for the production thereof | ELI LILLY AND COMPANY (US) | 1980-04-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12616773-B2 | Bioadhesive compositions and methods of making the same | F12, F13A1, EPCAM | GRIK1 1478/4885GRIK2 1431/4885CYP2C19 1898/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.